Rich Fante has been named president of AstraZeneca's U.S. business. Mr. Fante takes over from Tony Zook, whose role was expanded after recently being named president of MedImmune, AZ's wholly-owned biologics business. Mr. Zook is chief executive officer of AstraZeneca North America and head of global marketing.

Said Mr. Zook, "Rich brings strong leadership and a wealth of experience that is invaluable to our business and for improving patient health."

Previously, Mr. Fante served as AZ's vice president, Brand Strategy & Portfolio Operations. He led the development and execution of marketing strategies for all AZ brands in the U.S. He has held a number of leadership roles in his 13 years at AZ, including vice president-Primary Care for the gastrointestinal and respiratory franchises, including Nexium and Pulmicort Respules.

For breaking news from this year's AAPS conference, visit our Live from AAPS site!

News from our sister sites